Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
F&O
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
Glenmark Pharmaceuticals Ltd.
NSE: GLENMARK
|
BSE: 532296
|
ISIN: INE935A01035
|
Industry: Pharmaceuticals
|
Strong Performer, Getting Expensive
2061.0000
9.10
(
0.44
%)
NSE
Sep 08, 2025
13:49 PM
61.58% Gain from 52W Low
Volume:
642.2K
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Glenmark Pharmaceuticals Ltd.
22 May 2023
2061.00
0.44%
Glenmark Pharma
Hold:
Glenmark Pharmaceuticals Ltd.
by
ICICI Direct
Target: 580
Target
ICICI Direct
Number of FII/FPI investors decreased from 404 to 396 in Jun 2025 qtr
More from Glenmark Pharmaceuticals Ltd.
Recommended
Market trades higher, Diamond Power bags a Rs 184.7 crore order from Adani Energy
Trendlyne Marketwatch |
08 Sep 2025, 01:43PM
Five Interesting Stocks Today - September 5, 2025
The Baseline |
05 Sep 2025
Earnings Call Transcript - Q4FY20 for Glenmark Pharmaceuticals
|
29 Jun 2020